Lichen Sclerosus vs Vaginal Atrophy: How to Tell the Difference

Vulvar itching, dryness, and painful intercourse can point to two very different conditions, and treating the wrong one could delay real relief for months or years. Both lichen sclerosus and vaginal atrophy cause similar symptoms in menopausal women, but one responds beautifully to bioidentical hormone therapy while the other requires a completely different approach. Understanding which condition you’re actually dealing with is the first step toward finding solutions that work.

Understanding Vaginal Atrophy: Causes, Symptoms, and Diagnosis

What Causes Vaginal Atrophy?

Vaginal atrophy, now medically termed Genitourinary Syndrome of Menopause (GSM), develops when declining estrogen levels cause thinning, drying, and inflammation of vaginal tissues. This condition affects up to 84% of women six years after menopause, yet many suffer in silence without seeking treatment.

During reproductive years, estrogen keeps vaginal tissues thick, elastic, and well-lubricated. When estrogen declines during perimenopause and menopause, tissues lose their structural support:

• Blood flow decreases
• Natural lubrication diminishes
• The vaginal lining becomes fragile and prone to irritation

The underlying issue isn’t disease or dysfunction. It’s a hormone imbalance. Your body simply needs what it’s missing: adequate estrogen to maintain healthy vaginal tissue.

Common Symptoms of Atrophic Vulvovaginitis

GSM symptoms typically develop gradually and worsen without treatment:

• Vaginal dryness: Often the first and most commonly reported symptom of vaginal atrophy, caused by declining estrogen levels
• Burning and irritation: Persistent discomfort that isn’t relieved by standard moisturizers
• Painful intercourse: Due to tissue thinning and lack of natural lubrication
• Bleeding after sex: Fragile vaginal tissue can bleed with friction, but any postmenopausal bleeding should be evaluated by a healthcare provider to rule out other causes
• Urinary symptoms: Urgency, frequency, and recurrent UTIs occur as urethral tissue thins
• Vulvar itching: Can range from mild to severe and may overlap with symptoms of lichen sclerosus

Importantly, GSM is often persistent and can worsen without treatment. The good news is that vaginal hormone therapy can significantly improve dryness, discomfort, and tissue health by addressing the underlying estrogen decline. Many women experience lasting relief with consistent treatment.

How is Vaginal Atrophy Diagnosed?

Diagnosis typically relies on clinical examination and symptom assessment rather than extensive testing. Your provider will look for:

• Thin, pale vaginal tissue lacking normal rugae (folds)
• Elevated vaginal pH (above 5.0, compared to normal 3.8-4.5)
• Narrowed vaginal opening
• Tissue that bleeds easily when touched

Unlike lichen sclerosus, biopsy is usually unnecessary for diagnosing vaginal atrophy. The clinical picture combined with menopausal status provides sufficient information for diagnosis and treatment planning.

Lichen Sclerosus Explained: Signs, Progression, and Risk Factors

What is Lichen Sclerosus?

Lichen sclerosus is a chronic inflammatory skin condition linked to immune dysfunction that primarily affects the vulva and perianal area. Unlike vaginal atrophy, this condition involves chronic skin inflammation, with autoimmune mechanisms believed to play a role.

The exact cause remains unknown, but research suggests a combination of genetic predisposition, autoimmune mechanisms, and possibly hormonal factors. What’s crucial to understand: estrogen therapy does not treat the underlying inflammation of lichen sclerosus. However, women who also experience vaginal atrophy may benefit from vaginal estrogen to relieve dryness and discomfort. Lichen sclerosus still requires its own specialized treatment, typically with prescription corticosteroids.

Recognizing the Signs of Lichen Sclerosus

Lichen sclerosus presents with distinctive visual and symptomatic features.

Visual characteristics:

• White, porcelain-like patches on vulvar skin
• Thin, wrinkled, fragile texture resembling cigarette paper
• Classic hourglass pattern around the vulva and anus
• Possible purpura (bruising), fissures, and erosions
• Clitoral phimosis and labial fusion in advanced cases

Symptom profile:

• Severe, intractable itching: One of the most common symptoms of lichen sclerosus, often becoming worse at night and sometimes disrupting sleep 
• Pain and soreness: Especially with sitting, exercise, or tight clothing
• Bleeding and tearing: From minimal trauma due to tissue fragility
• Painful intercourse: Due to scarring rather than dryness
• Constipation: If perianal skin is involved

One important distinction: lichen sclerosus primarily affects external vulvar and perianal skin, typically sparing the vaginal canal. Internal vaginal symptoms may suggest GSM or another condition, but they don’t rule out lichen sclerosus, since both conditions can occur together.

Who is at Risk for Lichen Sclerosus?

Lichen sclerosus follows a bimodal age distribution:

• Prepubertal girls: Peak around ages 7-8
• Postmenopausal women: Most common onset after age 50

Risk factors include personal or family history of autoimmune conditions (thyroid disease, vitiligo, alopecia areata), prior vulvar trauma or scarring, and genetic predisposition. Unlike vaginal atrophy, which affects most menopausal women to some degree, lichen sclerosus is relatively uncommon.

Key Differences: Lichen Sclerosus vs. Vaginal Atrophy

Symptom Comparison: Itching, Dryness, and Bleeding

While both conditions cause discomfort, the nature and severity of symptoms differ significantly. Lichen sclerosus typically presents with intense itching as the primary complaint, often nocturnal and unbearable. Women describe it as different from any itch they’ve experienced and unresponsive to standard anti-itch treatments. The itching severity is often intense but may be mild or absent in some cases.

Vaginal atrophy, by contrast, typically presents with vaginal dryness as the main concern. Itching can occur but is variable, ranging from mild to severe. Pain location also differs:

• Lichen sclerosus: Usually affects vulvar or perianal skin
• Vaginal atrophy: Affects the vaginal canal, vaginal opening, or vulva

Intercourse pain stems from scarring and fissures in lichen sclerosus, while in vaginal atrophy it results from dryness and tissue thinning. Urinary symptoms present differently too. Lichen sclerosus may cause obstruction if severe, while vaginal atrophy typically causes frequency, urgency, and recurrent UTIs.

Visual Cues: What to Look For

The appearance of affected tissue tells much of the story.

Lichen Sclerosus:

• Ivory-white, shiny patches
• Architectural changes (labial fusion, clitoral burying)
• External vulva and perianal area only
• Possible fissures, erosions, hemorrhagic spots

Vaginal Atrophy:

• Thin, pale pink tissue (not white)
• Loss of vaginal rugae
• Narrowed introitus
• Friable tissue that bleeds easily
• Affects vaginal canal and external tissues

Underlying Causes and Pathology

The fundamental difference lies in what’s driving each condition. Vaginal atrophy results from estrogen decline. This is a hormone imbalance condition where tissues need hormone restoration to heal. The root cause is addressable with appropriate bioidentical hormone therapy.

Lichen sclerosus involves chronic skin inflammation, with autoimmune mechanisms believed to play a role. Unlike vaginal atrophy, it is not primarily caused by declining estrogen. Hormone therapy alone cannot treat the underlying inflammation, making specialized treatment essential.

This distinction determines everything about treatment. Applying estrogen to lichen sclerosus won’t address the inflammation. Using corticosteroids alone for true vaginal atrophy misses the root cause entirely.

Effective Treatments for Vaginal Atrophy and Dryness

Hormonal Therapy Options for Atrophy

When vaginal atrophy is correctly diagnosed, hormone restoration offers remarkable relief. The 2025 AUA guidelines strongly recommend local low-dose vaginal estrogen for improving vaginal dryness, irritation, and other GSM symptoms.

Options include:

• Vaginal estrogen creams: Deliver estrogen directly to affected tissues
• Vaginal estradiol tablets: Low-dose local therapy
• Vaginal DHEA: Converts to estrogen locally
• Systemic hormone therapy: Addresses whole-body symptoms simultaneously

Oestra™ combines bioidentical estradiol and progesterone in a vaginal cream that addresses both local and systemic hormonal symptoms. The vaginal delivery route achieves 4x higher bioavailability compared to oral forms, bypassing liver metabolism that reduces effectiveness of oral hormones.

According to Inner Balance’s internal data, 97% of women using Oestra™ reported improvement in vaginal dryness after approximately six months of treatment. Some women may notice relief within the first few weeks, while others experience gradual improvements with continued use.

Non-Hormonal Approaches to Vaginal Dryness

For mild symptoms or as adjuncts to hormone therapy:

• Vaginal moisturizers: Applied every 1-3 days to maintain tissue hydration
• Lubricants: Used during intercourse for immediate comfort
• Regular sexual activity: Increases blood flow to vaginal tissues
• Pelvic floor therapy: Addresses muscle tension contributing to discomfort

These approaches help manage symptoms but don’t address the underlying hormone imbalance causing tissue changes.

Lifestyle and Self-Care Strategies

Supporting vaginal health goes beyond direct treatment:

• Wear breathable cotton underwear
• Avoid irritating soaps, douches, and fragranced products
• Stay hydrated
• Maintain a balanced diet to support overall health, while recognizing that food and supplements cannot replace hormone therapy for GSM or prescribed corticosteroids for lichen sclerosus

Managing Lichen Sclerosus: Treatment and Symptom Relief

First-Line Treatments for Lichen Sclerosus

Lichen sclerosus requires a fundamentally different approach from vaginal atrophy. The British Association of Dermatologists guidelines recommend ultrapotent topical corticosteroids as first-line treatment:

Clobetasol propionate 0.05% ointment:

• Month 1: Apply once daily
• Month 2: Apply every other day
• Month 3: Apply twice weekly
• Maintenance: Continue as needed long-term

This treatment is highly effective for controlling lichen sclerosus, with many patients experiencing significant relief from itching and inflammation. According to clinical guidance, symptoms often improve within the first several weeks, although ongoing maintenance treatment may be necessary to prevent flare-ups and scarring.

Importantly, ultrapotent steroids applied to vulvar skin are safe for long-term use. The concern about steroid skin thinning that applies elsewhere on the body is less relevant in this specialized treatment context.

Coping with Itching and Discomfort

While waiting for treatment to take effect:

• Apply petroleum jelly or plain emollients to protect fragile skin
• Wear loose, cotton clothing
• Avoid irritants including scented products, fabric softeners, and harsh soaps
• Consider cool compresses for acute itching
• Avoid scratching, which worsens tissue trauma

Long-Term Management and Monitoring

Lichen sclerosus requires lifelong surveillance because of the estimated 4-5% risk of vulvar squamous cell carcinoma development. Regular follow-up appointments every 6-12 months allow providers to:

• Monitor for suspicious changes (new ulcers, nodules, areas that don’t respond to treatment)
• Adjust maintenance therapy as needed
• Perform biopsies of concerning areas
• Track architectural changes over time

This ongoing monitoring relationship is essential, as early detection of malignant transformation dramatically improves outcomes.

When to Seek Medical Advice for Vulvar Itching and Discomfort

Signs Your Symptoms Need Attention

Don’t dismiss vulvovaginal symptoms as just menopause. Seek evaluation if you experience:

• Itching that doesn’t respond to over-the-counter treatments
• Pain during intercourse that persists despite lubricants
• White patches or visible skin changes
• Bleeding unrelated to menstruation
• Symptoms lasting more than a few weeks
• Any new lumps, ulcers, or rapidly changing areas

The Importance of Early Diagnosis

For both conditions, earlier treatment leads to better outcomes. Early hormone restoration for vaginal atrophy prevents progressive tissue changes and maintains vaginal function. Severe atrophy with significant stenosis takes longer to reverse.

For lichen sclerosus, early corticosteroid treatment helps prevent further scarring and architectural changes and may reduce the risk of vulvar cancer. Advanced LS with labial fusion or clitoral burial may require surgical intervention.

Finding the Right Healthcare Provider

Start with your gynecologist or primary care provider for a thorough vulvar examination. If lichen sclerosus is suspected, a vulvar biopsy may be recommended to confirm the diagnosis or rule out concerning skin changes. Your provider may also refer you to a dermatologist or gynecologist specializing in vulvar disorders.

For vaginal atrophy symptoms, Inner Balance provides comprehensive telehealth hormone therapy consultations with board-certified physicians licensed in all 50 states. Getting properly evaluated is the first step toward targeted treatment.

When Both Conditions Occur Together

Because both conditions can occur after menopause, some women experience lichen sclerosus and vaginal atrophy at the same time. When this happens, each condition requires targeted treatment.

If you have both conditions:

1. Treat lichen sclerosus with prescribed corticosteroids
2. Add vaginal estrogen therapy for GSM symptoms concurrently
3. Coordinate application sites and timing with your provider
4. Monitor response to both treatments separately

Treating coexisting GSM with vaginal estrogen can help relieve hormone-related dryness and irritation, while corticosteroids address the inflammation caused by lichen sclerosus. Don’t assume that treating one condition will address both.

Finding Relief Through Comprehensive Hormone Care

Vaginal atrophy rarely occurs in isolation. Women experiencing GSM may also deal with hot flashes, night sweats, sleep disruption, mood changes, and brain fog. Many of these symptoms are connected to the hormonal changes of menopause, particularly declining estrogen, although their severity and underlying causes can vary.

Women with PCOS, endometriosis, or postpartum hormonal changes may also experience hormone-related symptoms at different life stages. However, these conditions involve distinct hormonal patterns and require individualized evaluation and treatment.

The Inner Balance Approach to Hormone Restoration

Bioidentical hormones match your body’s own hormones molecule for molecule. Bioidentical progesterone plays an important role in hormone therapy, particularly in protecting the uterine lining when systemic estrogen is prescribed to women with a uterus. While it may offer tolerability advantages over certain synthetic progestins, side effects and individual risks still need to be considered.

Oestra™ delivers both estradiol and progesterone through vaginal application, providing:

• Local relief for vaginal dryness and atrophy
• Systemic absorption for whole-body symptom improvement
• Superior bioavailability compared to oral forms
• Hormone delivery designed to support consistent systemic exposure with personalized dosing

Addressing Hormonal Aging Inside and Out

Hormone changes affect every system in your body, including your skin. As estrogen declines, skin loses collagen, elasticity, and moisture. BodyMatched™ Anti-Aging Face Cream addresses these changes topically with prescription-strength estriol and anti-aging compounds, targeting hormonally aging skin from the outside while Oestra works from within.

This inside-out approach recognizes that hormone imbalance manifests throughout your body. Addressing the root cause comprehensively provides more complete relief than treating individual symptoms in isolation.

Frequently Asked Questions

Is vaginal atrophy curable, or is it a lifelong condition?

Vaginal atrophy responds well to consistent hormone therapy, and many women experience significant improvements in comfort and vaginal tissue health. Because estrogen levels remain low after menopause, symptoms may return when treatment stops, making ongoing vaginal hormone therapy beneficial for many women. Most women continue some form of treatment long-term for maintained relief.

Are there any long-term risks associated with lichen sclerosus?

The primary long-term concern is the estimated 3-5% risk of developing vulvar squamous cell carcinoma. This risk is why regular monitoring is essential. Warning signs include new ulcers, nodules, or areas that don’t respond to steroid treatment. Untreated LS can also cause irreversible scarring affecting sexual function and urination.

How quickly can I expect to see results from treatments for vaginal atrophy?

Many women begin noticing relief from vaginal dryness and irritation within the first few weeks of vaginal estrogen therapy, with continued improvement over several months. Inner Balance reports that 90% of women experienced improvements in sleep, mood, and anxiety within 10-14 days, based on company-reported results. More advanced vaginal atrophy may require additional time and consistent treatment.

Can I use over-the-counter creams for vulvar itching, or do I need a prescription?

Over-the-counter anti-itch creams may provide temporary relief but won’t address the underlying cause of either condition. Hydrocortisone creams available without prescription are not strong enough to treat lichen sclerosus effectively. For GSM, vaginal moisturizers help manage dryness but don’t reverse tissue changes like prescription estrogen therapy does.

What is the role of diet and lifestyle in managing these conditions?

While diet and lifestyle cannot cure either condition, they play supportive roles. For vaginal atrophy, staying well-hydrated, avoiding irritants, maintaining regular sexual activity, and eating foods that support hormone balance can complement hormone therapy. For lichen sclerosus, gentle hygiene practices, avoiding irritants, and wearing breathable fabrics reduce symptom flares.